Enhancement of anti-inflammatory and antinociceptive actions of red ginseng extract by fermentation

Journal of Pharmacy and Pharmacology

Volumn 64, Issue 5, 2012, Pages 756-762

  Jung, Hyun Joo ^a,b   Choi, Hojin ^c   Lim, Hye Won ^d   Shin, Daehyun ^e   Kim, Hacksoo ^f   Kwon, Bin ^g   Lee, Jong Eun ^b   Park, Eun Hee ^a   Lim, Chang Jin ^h  

^a Sookmyung Women's University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Hanyang University   (South Korea)

^d Chuncheon Biotechnology Foundation   (South Korea)

^e R and D Center   (South Korea)

^f Seoul Cosmetics Co Incheon   (South Korea)

^g Bifido Co   (South Korea)

^h Kangwon National University   (South Korea)

Author keywords

anti inflammatory; antinociceptive; Bifidobacterium; fermentation; red ginseng

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINOCICEPTIVE AGENT; DEXAMETHASONE; FERMENTED RED GINSENG EXTRACT; INDOMETACIN; NITRATE; NITRIC OXIDE; PLANT EXTRACT; RED GINSENG EXTRACT; UNCLASSIFIED DRUG;

ABDOMINAL WALL MUSCULATURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; FERMENTATION; GINSENG; IC 50; IN VIVO STUDY; INFLAMMATION; MACROPHAGE ACTIVATION; MUSCLE CONTRACTION; NONHUMAN; PAIN; RAT; RED GINSENG;

ABDOMINAL PAIN; ACETIC ACID; ANALGESICS; ANGIOGENESIS INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CARRAGEENAN; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; FERMENTATION; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED ICR; NITRITES; PANAX; PERMEABILITY; PHYTOTHERAPY; PLANT PREPARATIONS;

EID: 84862812499     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2012.01460.x     Document Type: Article

References (37)

1. Tang W, Eisenbrand G,. Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine. Berlin: Springer-Verlag, 1992: 711-737.
2. Kang KS, et al,. Increase in the free radical scavenging activity of ginseng by heat-processing. Biol Pharm Bull 2006; 29: 750-754.
3. Konoshima T, et al,. Anti-tumor-promoting activity of majonoside-R2 from Vietnamese ginseng, Panax vietnamensis Ha et Grushv. (I). Biol Pharm Bull 1998; 21: 834-838.
4. Park JD,. Recent studies on the chemical constituents of Korean ginseng (Panax ginseng C. A. Meyer). Korean J Ginseng Sci 1996; 20: 389-415.
5. Chon H, et al,. Comparison of aqueous plant extracts before and after fermentation with Lactobacillus paracasei LS-2 on cytokine induction and antioxidant activity. Nat Prod Commun 2010; 5: 1277-1282.
6. Hu Y, et al,. Characterization of fermented black soybean natto inoculated with Bacillus natto during fermentation. J Sci Food Agric 2010; 90: 1194-1202.
7. Su ZY, et al,. Black soybean promotes the formation of active components with antihepatoma activity in the fermentation product of Agaricus blazei. J Agric Food Chem 2008; 56: 9447-9454.
8. Lee HY, et al,. Enhancement of antimicrobial and antimutagenic activities of Korean barberry (Berberis koreana Palib.) by the combined process of high-pressure extraction with probiotic fermentation. J Sci Food Agric 2010; 90: 2399-2404.
9. Whittle BA. The use of changes in capillary permeability in mice to distinguish between narcotic and nonnarcotic analgesics. Br J Pharmacol Chemother 1964; 22: 246-253.
10. Ghosh AK, et al,. Cyclooxygenase-2-mediated angiogenesis in carrageenan-induced granulation tissue in rats. J Pharmacol Exp Ther 2000; 295: 802-809.
11. Olajide OA, et al,. Studies on the anti-inflammatory, antipyretic and analgesic properties of Alstonia boonei stem bark. J Ethnopharmacol 2000; 71: 179-186.
12. Shermam MP, et al,. Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochem Biophys Res Commun 1993; 191: 1301-1308.
13. Song YS, et al,. Anti-angiogenic and inhibitory activity on inducible nitric oxide production of the mushroom Ganoderma lucidum. J Ethnopharmacol 2004; 90: 17-20.
14. Vogel HG, Vogel WH,. Drug Discovery and Evaluations: Pharmacological Assays. Berlin: Springer, 1997: 402-403.
15. Singh VK, et al,. Modulation of autoimmune diseases by nitric oxide. Immunol Res 2000; 22: 1-19.
16. Iurlaro M, et al,. Beta interferon inhibits HIV-1 Tat-induced angiogenesis: synergism with 13-cis retinoic acid. Eur J Cancer 1998; 34: 570-576.
17. Cho WC, et al,. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur J Pharmacol 2006; 550: 173-179.
18. Jin SH, et al,. Korean red ginseng saponins with low ratios of protopanaxadiol and protopanaxatriol saponin improve scopolamine-induced learning disability and spatial working memory in mice. J Ethnopharmacol 1999; 66: 123-129.
19. Jung NP, Jin SH,. Studies on the physiological and biochemical effects of Korean ginseng. Korean J Ginseng Sci 1996; 20: 431-471.
20. Kang TH, et al,. Effects of red ginseng extract on UVB irradiation-induced skin aging in hairless mice. J Ethnopharmacol 2009; 123: 446-451.
21. Kim JH, et al,. Comparison of the antiobesity effects of the protopanaxadiol- and protopanaxatriol-type saponins of red ginseng. Phytother Res 2009; 23: 78-85.
22. Lee SH, et al,. The antistress effect of ginseng total saponin and ginsenoside Rg3 and Rb1 evaluated by brain polyamine level under immobilization stress. Pharmacol Res 2006; 54: 46-49.
23. Park EK, et al,. Antiallergic activity of ginsenoside Rh2. Biol Pharm Bull 2003; 26: 1581-1584.
24. Park EK, et al,. Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosyntheses of RAW264.7 cells induced by lipopolysaccharide. Biol Pharm Bull 2005; 28: 652-656.
25. Choi KT,. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C. A. Meyer. Acta Pharmacol Sin 2008; 29: 1109-1118.
26. Gillis CN,. Panax ginseng pharmacology: a nitric oxide link? Biochem Pharmacol 1997; 54: 1-8.
27. Kang KS, et al,. Study on the nitric oxide scavenging effects of ginseng and its components. J Agric Food Chem 2006; 54: 2558-2562.
28. Jaenicke B, et al,. Effect of Panax ginseng extract on passive avoidance retention in old rats. Arch Pharm Res 1991; 14: 25-29.
29. Kim DY, Chang JC,. Radioprotective effect of ginseng components on antioxidant enzymes, glutathione and lipid peroxidation of liver in γ-irradiated mice. Korean J Ginseng Sci 1998; 22: 1-10.
30. Sato K, et al,. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside Rb2. Biol Pharm Bull 1994; 17: 635-639.
31. Sengupta S, et al,. Modulating angiogenesis. The yin and the yang in ginseng. Circulation 2004; 110: 1219-1225.
32. Bae EA, et al,. Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-gamma-stimulated BV-2 microglial cells. Planta Med 2006; 72: 627-633.
33. Choi K, et al,. Ginsenosides compound K and Rh(2) inhibit tumor necrosis factor-alpha-induced activation of the NF-kappaB and JNK pathways in human astroglial cells. Neurosci Lett 2007; 421: 37-41.
34. Kang KS, et al,. Preventive effect of 20(S)-ginsenoside Rg3 against lipopolysaccharide-induced hepatic and renal injury in rats. Free Radic Res 2007; 41: 1181-1188.
35. Park EH, et al,. Inhibitory effect of ginsenoside Rb1 and compound K on NO and prostaglandin E2 biosynthesis of RAW264.7 cells induced by lipopolysaccharide. Biol Pharm Bull 2005; 28: 652-656.
36. Trinh HT, et al,. Bifidus fermentation increases hypolipidemic and hypoglycemic effects of red ginseng. J Microbiol Biotechnol 2007; 17: 1127-1133.
37. Matsuki T, et al,. Distribution of Bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene targeted species-specific primers. Appl Environ Microbiol 1999; 65: 4506-4512.